Businesswire·2025-11-06 22:03Core Insights - AN2 Therapeutics, Inc. is participating in the 8th Annual Evercore HealthCONx Conference, with CEO Eric Easom scheduled for a fireside chat on December 3, 2025 [1][2] - The company focuses on developing novel small molecule therapeutics from its boron chemistry platform, targeting diseases such as Chagas disease, melioidosis, and NTM lung disease [3] Event Details - The fireside chat will take place at 10:50 AM ET on December 3, 2025, and management will be available for one-on-one meetings [2] - A webcast of the event will be accessible on the company's investor website, with an archived replay available for at least 30 days [2] Company Overview - AN2 Therapeutics is dedicated to discovering and developing high-impact drugs that address critical medical needs, particularly in infectious diseases and oncology [3] - The company has a pipeline of boron-based compounds under development, including a promising candidate for Chagas disease [3][7]